Skip to comments.Encouraging Results on Ivermectin Clinical Trial for Reducing Mild COVID-19
Posted on 01/19/2021 4:40:40 PM PST by FreedomForce
A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission. The study, which is part of the SAINT project and has been led by the University of Navarra Clinic and the Barcelona Institute for Global Health (ISGlobal), an institution supported by the “la Caixa” Foundation, warrants further exploration in larger clinical trials. The findings of the pilot study have been published in EClinicalMedicine, a clinical journal published by The Lancet.
(Excerpt) Read more at scitechdaily.com ...
No,no,no. Aren’t they sposed to wait till they’re damned near dead before they try it?
Hope y’all don’t mind me posting this on Ivermectin threads. I’ve been doing it for a while.
If we had a public health edifice that was worth anything, front line health care workers and public-facing store employees would be on Covid prophylaxis. The Federal public health agencies (FDA/NIH/CDC) have seemingly completely ignored cheap effective re-purposed therapeutics that could have significantly reduced deaths and transmission.
Ivermectin is effective for COVID-19: meta analysis of 33 studies
Front Line COVID-19 Critical Care Alliance
Key protocols from this group use Ivermectin.
COVID Care for Clinicians
Ditto this group.
India has been using HCQ and Ivermectin for many months as therapeutics and for prophylaxis. Their curves are quite impressive, scroll down to see them here.
Anyone able to interpret a basic graph will be impressed. Why is this not being talked about in Western media?
Also from India:
Ziverdo Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. It is currently indicated in the first line treatment for COVID-19 positive patients. Quadruple Therapy with Ivermectin is effective in treating COVID-19
That’s a link to an Indian online pharmacy selling that Covid treatment kit for under $2, just add vitamin D3.
There are somewhere around 40 trials of Ivermectin completed so far. About 16 or so are random, controlled trials. Others are observational.
All of them show the Ivermectin works for pretty much all stages of the disease except the very end.
Prophylaxis, post exposure, mild, medium and even helps in severe. It just won't bring people back from death's door.
The NIH updated their guidance on it, allowing your doctor to prescribe it. There are other ways to take it to prevent the disease in the first place. It's a very safe drug. Now if I just find out where to get my horse tail trimmed....
There has been several trials and it works.
A Dr just died on Texags site. He certainly knew about Ivermectin and other forms of treatment. He was at home recuperating and doing better. People kept asking for an update and then news came that he died.
Ivermectin didnt keep Myfreedoctor out of the hospital with bilateral pneumonia..but perhaps it kept him from needing a vent.
It did bring back someone from deaths door but that may be a rare case. The family of a Buffalo woman had to go to court.
I saw another story about someone sneaking it into the hospital to try to save someone. The story didnt go into how they snuck it in since visitation wasn’t allowed.
We have sent two letters already with links to good information on Ivermectin, including that of Dr. Pierre Kory. Conservative Talk Show Host Hugh Hewitt interviewed Dr. Kory. That interview transcript and the audio (@13 minutes) is available on Hewitt's web site.
A twelfth physician told me not to expect much response from the physicians because they are under pressure from the CDC and NIH to push vaccines, NOT early therapeutics.
Our own representative to the Indiana House is a pharmacist who owns his own pharmacy. I asked him to verify whether there is any legal problem for Indiana physicians if they prescribe Ivermectin, HCQ, Budesonide, etc., for Covid. Answer from the State Health Department: No problem; no prohibitions. Why do so few physicians, then, prescribe early treatment? CDC ! NIH !
We push ahead. I will add your links to my third letter. Thanks again.
here is what a Dr said on texags site
COVID is brand new. No one know what really works and what doesn’t. We’re all working off our best judgement. For some doctors that’s “try everything that might work”, for others it’s “try only things that could most likely work”, and for others it’s “don’t try anything unless we know it works”. Those are all valid and rational approaches to something like this, and there are no wrong answers. The important thing is for the doctor and the patient to agree on the overall plan.
As of a few days ago, the NIH’s recommendation for Ivermectin is the same as for any of the monoclonal antibodies that cause no controversy whatsoever.
The problem with ivermectin is the same as for HCQ: no private group is going to fund a large expensive RCT, so the only option is to have a government funded study. There is no legitimate reason that the NIH hasn’t done this. Very strange. I’m sure there’s a perfectly innocent explanation though.
Audio of Hewitt's interview of Dr. Pierre Kory:
The website for Dr. Kory's group:
There are myriad studies already on Ivermectin.
Yes, but according to the NIH, they are “small” and or “poorly designed” and “additional study is needed” to change their recommendation. The same problem is in play, sometimes even more severely in Europe and the UK. The developed countries national health authorities are all ignoring the importance of time, insisting that doctors and patients wait for better evidence.
As far as I can tell, the data for ivermectin being both safe and efficacious are beyond doubt from a population standpoint. Can we say that (for example) the I-MASK+ regimen from FLCCC will help this particular individual? No, not really. But would wide adoption and early treatment remove the overcrowding from the hospitals? Yes, we can say that we know that at this point.
But taking a risk/reward statistical approach is NOT the way medicine is done in the current era. My prediction is that the FLCCC docs will be able to provide the NIH with the level of security they want within the next 4- 6 weeks, and the rest of the developed world will follow suit. At that point, there will be insufficient supplies for a period of time as every doctor starts prescribing it as a standard of care.
Just saw this, sorry for the double-tap.
It’s going mainstream. Time to get a scrip before it starts flying off of the shelves.
A good friend my age 82, was admitted to our local hospital with a + Covid diagnosis. Besides his age, he is overweight and was in the hospital about a year ago with pneumonia.
He was admitted last ThursdayFriday and ended in a portable Covid ICU unit.
Besides standard treatment he received Remdesivir —
He was sent home to his 2nd floor apartment on Tuesday.
My wife talked to him briefly on Tuesday. He is a little weak and doing okay.
President Trump was given his first dose of remdesivir Oct. 2, and he will be given a five-day course, CNN reported. Remdesivir, made by Gilead (who gave it the brand name of Veklury), was granted emergency use authorization by the FDA on May 1 after a study showed it caused a 31 percent faster recovery time compared to a placebo.
Remdesivir is an intravenous drug that works by targeting the system coronaviruses use to replicate themselves. It has been previously tested for Ebola, but hasn’t been officially approved in any country. The FDA expanded its emergency use authorization for remdesivir Aug. 28, allowing it to be used on all hospitalized patients. It had previously only been authorized for those on ventilators or with low blood oxygen levels.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.